G
Glenmark Pharmaceuticals Ltd
PharmaceuticalsMidcap
About the company
Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
Performance
- Stock
- Loading Stock value
—
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 60.89 | 42.25 |
| PB Ratio | 7.20 | 6.29 |
| Dividend Yield | 0.11% | 0.45% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions